DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 177 filers reported holding DIPLOMAT PHARMACY INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $24,038,000 | -13.3% | 1,238,420 | +14.1% | 1.12% | -13.9% |
| Q2 2018 | $27,735,000 | +48.9% | 1,085,078 | +17.4% | 1.30% | +42.5% |
| Q1 2018 | $18,622,000 | -34.5% | 924,173 | -34.8% | 0.92% | -27.0% |
| Q4 2017 | $28,447,000 | -15.0% | 1,417,396 | -12.3% | 1.25% | -8.7% |
| Q3 2017 | $33,484,000 | +793.9% | 1,616,792 | +538.8% | 1.37% | +763.5% |
| Q2 2017 | $3,746,000 | – | 253,096 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |